Back in July, we were proud to win not one, but two Sparkies awards – HealthTech and The People’s Choice! It meant a lot, not just because the Bristol & Bath tech community recognised our work, but because it showed that our mission, to reduce uncertainty in epilepsy diagnosis, really resonates.
So, what have we been up to since then? Quite a bit…
Attending the ILAE conference
This month, we headed to the International League Against Epilepsy (ILAE) British Branch conference in Bournemouth to showcase BioEP, our digital biomarker that detects seizure risk in EEG data, even when it looks ‘normal’ to the human eye. Connecting with leading clinicians and researchers was a powerful reminder of how urgently innovation is needed in epilepsy diagnosis. We also hosted a symposium alongside Phil Tittensor, Consultant Nurse for the Epilepsies, and Dr Kelly St. Pier, Consultant Clinical Scientist at Young Epilepsy, exploring the science behind BioEP and how it’s being used in practice.
Alongside this, Neuronostics was invited to the International Epilepsy Congress in Lisbon, as winner of the 2024 Epilepsy Foundation Shark Tank competition. We gave a talk within the ILAE neurotechnology section, introducing BioEP, sharing results from our foundation studies, and outlining our ongoing clinical workshops.